美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Celgene Corporation Contingent Value Rights

0.1201

+0.015815.09%

成交量：1.75萬

成交額：2,693.92

市值：2.82億

市盈率：0.03

高：0.1700

開：0.1700

低：0.1201

收：0.1043

52周最高：0.2749

52周最低：0.0150

股本：23.44億

流通股本：23.42億

量比：0.40

換手率：0.00%

股息：- -

股息率：- -

每股收益(TTM):3.46

每股收益(LYR):3.01

淨資產收益率：36.05%

總資產收益率：9.84%

市淨率：0.02

市盈率(LYR):0.04

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Celgene Corporation Contingent Value Rights

交易所：

NYSE

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

- -

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Celgene is an integrated biopharmaceutical company that is engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory diseases. Co.'s products include REVLIMID&#174;, THALOMID&#174; and...

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CELG.RT/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CELG.RT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CELG.RT\",,,,,undefined,":{"symbol":"CELG.RT","market":"US","secType":"STK","nameCN":"Celgene Corporation Contingent Value Rights","latestPrice":0.1201,"timestamp":1773345600000,"preClose":0.104349,"halted":0,"volume":17496,"delay":0,"changeRate":0.15094538519774986,"floatShares":2341575720,"shares":2344184798,"eps":3.459905,"marketStatus":"已收盤","change":0.015751,"latestTime":"03-12 16:00:00 EDT","open":0.17,"high":0.17,"low":0.1201,"amount":2693.91634,"amplitude":0.478203,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":3.459905,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1773388800000},"marketStatusCode":5,"adr":0,"exchange":"NYSE","adjPreClose":0.104349,"volumeRatio":0.395685},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CELG.RT\",,,,,undefined,":{"symbol":"CELG.RT","floatShares":2341575720,"roa":"9.84%","roe":"36.05%","lyrEps":3.012859,"volumeRatio":0.395685,"shares":2344184798,"dividePrice":0,"high":0.17,"amplitude":0.478203,"preClose":0.104349,"low":0.1201,"week52Low":0.015,"pbRate":"0.02","week52High":0.274899,"institutionHeld":0.0393,"latestPrice":0.1201,"eps":3.459905,"divideRate":0,"volume":17496,"delay":0,"ttmEps":3.459905,"open":0.17,"prevYearClose":0.0719,"prevWeekClose":0.1199,"prevMonthClose":0.0977,"prevQuarterClose":0.0719,"fiveDayClose":0.1759,"twentyDayClose":0.1,"sixtyDayClose":0.0439},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CELG.RT\",params:#limit:5,,,undefined,":[{"date":"2026-04-30","symbol":"CELG.RT","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1777536000000,"name":null,"time":"盤前","dateTimestamp":1777521600000,"actualEps":null},{"date":"2026-02-05","symbol":"CELG.RT","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770282000000,"name":null,"time":"盤前","dateTimestamp":1770267600000,"actualEps":null},{"date":"2025-10-30","symbol":"CELG.RT","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761811200000,"name":null,"time":"盤前","dateTimestamp":1761796800000,"actualEps":null},{"market":"US","date":"2025-07-31","symbol":"CELG.RT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1753934400000,"reportTimeType":"pre","actualEps":null},{"date":"2025-04-24","symbol":"CELG.RT","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1745481600000,"name":null,"time":"盤前","dateTimestamp":1745467200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CELG.RT\",market:\"US\",,,undefined,":[{"executeDate":"2019-03-21","recordDate":"2019-03-23","paymentDate":"2019-03-25","value":0.035943,"currency":"USD"},{"executeDate":"2020-03-18","recordDate":"2020-03-19","paymentDate":"2020-03-20","value":0.1479,"currency":"USD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-03-08","value":0.142498,"currency":"USD"},{"executeDate":"2022-03-03","recordDate":"2022-03-06","paymentDate":"2022-03-07","value":0.104592,"currency":"USD"},{"executeDate":"2024-03-07","recordDate":"2024-03-09","paymentDate":"2024-03-11","value":0.019899,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CELG.RT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"stockEarnings":[{"period":"1week","weight":-0.3425},{"period":"1month","weight":0.1607},{"period":"3month","weight":1.6087},{"period":"6month","weight":1.9814},{"period":"1year","weight":1.087},{"period":"ytd","weight":0.4513}],"compareEarnings":[{"period":"1week","weight":-0.0128},{"period":"1month","weight":-0.0254},{"period":"3month","weight":-0.0186},{"period":"6month","weight":0.0288},{"period":"1year","weight":0.2166},{"period":"ytd","weight":-0.0082}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Celgene is an integrated biopharmaceutical company that is engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory diseases. Co.'s products include REVLIMID&#38;#174;, THALOMID&#38;#174; and...","yearOnYearQuotes":[{"month":1,"riseRate":0.6875,"avgChangeRate":0.054307},{"month":2,"riseRate":0.5625,"avgChangeRate":0.051646},{"month":3,"riseRate":0.3125,"avgChangeRate":-0.096757},{"month":4,"riseRate":0.2,"avgChangeRate":-0.085409},{"month":5,"riseRate":0.4,"avgChangeRate":0.000185},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.004029},{"month":7,"riseRate":0.4,"avgChangeRate":0.110786},{"month":8,"riseRate":0.533333,"avgChangeRate":0.044307},{"month":9,"riseRate":0.466667,"avgChangeRate":0.03929},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.104042},{"month":11,"riseRate":0.25,"avgChangeRate":0.008724},{"month":12,"riseRate":0.5,"avgChangeRate":0.084436}],"exchange":"NYSE","name":"Celgene Corporation Contingent Value Rights","nameEN":"Celgene Corporation Contingent Value Rights"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CELG.RT\",market:\"US\",,,undefined,":null}}